PMGC secures five-year royalty payment plan from Elevai Skincare sale through August 2031
Bitget2026/09/18 12:00- PMGC Holdings entered an interest-bearing payment agreement with Longevity Health Holdings to secure royalty payments tied to its January 2025 sale of the Elevai Skincare business.
- The deal converts a 5% net sales royalty into scheduled monthly payments of $10,000 starting Oct. 15, 2026, with all amounts due by Aug. 28, 2031.
- Longevity acknowledged a 2025 royalty payable of USD 94,937, with interest at the Wall Street Journal Prime Rate plus 1% from the original April 2026 due date.
- Future royalty and earnout amounts will roll into the same payment plan, with mandatory prepayments triggered by certain capital events.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Meta (META.US) data center's first high-yield bond is oversubscribed more than four times, strong demand drives premium issuance
The first junk bond issuance by the data center division of Meta Platforms attracted demand over four times the transaction size, with its enticing yields drawing in investors.
US stock index adjustments to take effect next Monday: Bloom Energy (BE.US) and Everpure (P.US) to be included in S&P 500, changes also for mid- and small-cap stocks
Bloom Energy, Illumina, and Everpure will be included in the S&P 500 index, while several other companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.
Is the Federal Reserve repeating the 2022-style rate hikes? Bank of America warns: Rates may return above 5%, suggests shorting two-year U.S. Treasuries.
Bank of America warns: With Waller at the helm, the Federal Reserve may raise interest rates above 5%, potentially repeating the events of 2022.
Crypto prices
More
